Service scope

Clinical Development

Early Phase

About Service

Early Phase. Early Insights. Early Decisions.

Starting from the compounds ~ the investigational new drug development to the optimized facilities for patients, and the best outcomes
DreamCIS desires to provide the comprehensive services along with data through many ways, such as the partnership hospitals, the criteria for the best suitable patients, the hospital laboratories, and the recruitment of patient populations under various diseases.

Making a right decision for early development is critical in success of portfolio.
With partnership with you, DreamCIS can help you move toward success with its innovative insight and deep understanding in order to improve the decision making.

DreamCIS has been engaging in early phase clinical studies in healthy individuals every year in partnership with Phase I specific clinical trial centers. It also provides the service to increase the efficiency and accelerate the clinical studies led by professionals specific for complicated early development with phase 1 study experiences for complicated anticancer or rare diseases with patients in addition to healthy individuals.

Service Scope

  • Biostatistics
  • Biomarkers (experts in Korea with contracted, China,US and ANZ)
  • Clinical Conduct
  • Consulting
  • Data Management
  • Integrated Protocols
  • Laboratory (China, Phase I unit centers in Korea)
  • Medical Writing
  • Volunteer, Patient and Special Population Recruitment
  • PK/PD Modeling & Simulation (China)
  • Project Management
  • Regulatory
  • Study Design


Respiratory System

  • Corticosteroids
  • Leukotriene-Inhibitors
  • Antihistamines
  • β2-agonists


  • Anti-Psychotics
  • Anti-Depressants
  • CNS-Stimulants
  • Anti-Epileptics
  • Anti-Parkinson
  • Anti-Emetics
  • Anxiolytic agents
  • Anti-Alzheimer
  • Anti-Migraine
  • NK1 antagonists